Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Carl Icahn Further Decreases Holding Of Family Dollar Stores, Inc. (FDO) Stock To 3.6%

Carl Icahn has dumped a huge chunk of his Family Dollar Stores, Inc. (NYSE:FDO) shares and is no longer the largest shareholder. In two recent filing with the Securities and Exchange Commission, Icahn has disclosed a decrease in his investment first to 6.87 million and then to 4.11 million shares of Family Dollar Stores, Inc. (NYSE:FDO). As a result, Icahn and his fund, Icahn Capital LP, now hold only 3.61% of the company’s common stock.

Carl Icahn as viking

As Family Dollar Stores, Inc. (NYSE:FDO) is set to be taken over by Dollar Tree, Inc. (NASDAQ:DLTR), Nelson Peltz is set to rip huge profits from the deal. In its latest 13F filing, Peltz’s fund, Trian Partners, reported ownership of approximately 8.36 million shares. John Paulson is another hedge fund guru who will register a fat profit on this investment in the company. His fund, Paulson & Co, owns approximately 6.47 million shares, down by 34% during the first quarter of 2014. Harris Associates, run by Natixis Global Asset Management, also holds a significant position in Family Dollar Stores, Inc. (NYSE:FDO): 6.21 million shares, down 5% during Q1.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!